Covid 19: Clinical Trials

9 trials for Covid 19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown. 9 Phase 2, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Unknown 9
Phase 35Unknown 5

Follow Covid 19: new trials by email Literature Review of Covid 19 trials Research Report on Covid 19

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients
Normoxic Allogenic UCMSC, Normal saline solution - Covid 19
Phase 2 / Phase 3UnknownKementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia422021-01-172021-11-24
Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients
Hydroxychloroquine - COVID 19
Phase 2 / Phase 3UnknownHamad Medical Corporation5002020-08-312020-08-11
Efficacy and Safety of Sirolimus in COVID-19 Infection
Sirolimus - COVID 19
Phase 2UnknownAlexandria University402020-08-152020-09-09
Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients
Acacia Senegal, Pectin - COVID 19
Phase 2 / Phase 3UnknownAl-Neelain University1102020-06-012020-05-12
Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications
Convalescent Plasma, Standard Care Therapy - COVID 19
Phase 2UnknownMax Healthcare Insititute Limited1002020-05-092020-07-22
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
Hydroxychloroquine Sulfate 200 MG, Placebo - COVID 19
Phase 2UnknownShaheed Zulfiqar Ali Bhutto Medical University2002020-05-012020-05-19
Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19
Infusion IV of Mesenchymal Stem cells - Covid 19
Phase 2UnknownInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran102020-05-012020-06-04
Oral 25-hydroxyvitamin D3 and COVID-19
Oral 25-Hydroxyvitamin D3 - COVID 19
Phase 2 / Phase 3UnknownTehran University of Medical Sciences15002020-04-142020-06-12
The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
Hydroxychloroquine, Remdesivir, (Standard of Care) SoC - SARS-CoV Infection, COVID 19
Phase 2 / Phase 3UnknownOslo University Hospital7002020-03-282020-04-14

Narrower conditions

COVID-19 (9)  ·  Cytokine Release Syndrome (1)  ·  Severe Acute Respiratory Syndrome (1)  ·  Virus Diseases (1)

Broader conditions

Coronaviridae Infections (9)  ·  Coronavirus Infections (9)  ·  Infections (9)  ·  Lung Diseases (9)  ·  Nidovirales Infections (9)  ·  Pneumonia (9)  ·  Pneumonia, Viral (9)  ·  RNA Virus Infections (9)  ·  Respiratory Tract Diseases (9)  ·  Respiratory Tract Infections (9)  ·  Virus Diseases (8)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Shock (1)

Interventions

Hydroxychloroquine (3)  ·  Calcifediol (1)  ·  Gum Arabic (1)  ·  Pectins (1)  ·  Saline Solution (1)  ·  Sirolimus (1)  ·  Standard of Care (1)  ·  remdesivir (1)

Sponsors

Al-Neelain University (1)  ·  Alexandria University (1)  ·  Hamad Medical Corporation (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia (1)  ·  Max Healthcare Insititute Limited (1)  ·  Oslo University Hospital (1)  ·  Shaheed Zulfiqar Ali Bhutto Medical University (1)  ·  Tehran University of Medical Sciences (1)

Countries

Egypt (1)  ·  India (1)  ·  Indonesia (1)  ·  Iran (1)  ·  Mexico (1)  ·  Norway (1)  ·  Pakistan (1)  ·  Sudan (1)

Top investigators

Ahmad Faried, Prof. MD (1)  ·  Andreas Barratt-Due, MD, PhD (1)  ·  Anne Margarita Dyrhol Riise, MD, Professor (1)  ·  Arash Shirvani, MD, PhD (1)  ·  Arief Nurudin, MD PhD (1)  ·  Ayman I Baess, MD (1)  ·  Fibhaa Syed, FRCP (1)  ·  Inge Christoffer Olsen, PhD (1)  ·  Katerina Nezvalova-Henriksen, Pharm D, PhD (1)  ·  Michael F Holick, PhD,MD (1)  ·  Moawia M Mukhtar, PhD (1)  ·  Mohamadali Sahraian, MD (1)  ·  Mohamed Mamdouh Elsayed, MD (1)

Results publications

PMID 29859173, PMID 32085846, PMID 32214286, PMID 32265310, PMID 32281062, PMID 32756149, PMID 32891160, PMID 33757717, PMID 34251903, PMID 34350582, PMID 35876699, PMID 36695483, PMID 39533001